Benefits from the Use of a Pimecrolimus-Based Treatment in the Management of Atopic Dermatitis in Clinical Practice

Publisher： Karger

E-ISSN： 1421-9832|213|4|313-318

ISSN： 1018-8665

Source： Dermatology, Vol.213, Iss.4, 2006-12, pp. : 313-318

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rosaceiform Dermatitis with Follicular Demodex after Treatment of Facial Atopic Dermatitis with 1% Pimecrolimus Cream

By  

Dermatology, Vol. 207, Iss. 2, 2003-08 ,pp. : 205-207

Karger

Access to resources Recommend Favorite

Clinical Management of Atopic Eczema with Pimecrolimus Cream 1% (Elidel®) in Paediatric Patients

By  

Dermatology, Vol. 215, Iss. 1, 2007-12 ,pp. : 3-17

Karger

Access to resources Recommend Favorite

Belgian Observational Drug Utilization Study of Pimecrolimus Cream 1% in Routine Daily Practice in Atopic Dermatitis

By  

Dermatology, Vol. 217, Iss. 2, 2008-06 ,pp. : 156-163

Karger

Access to resources Recommend Favorite

Pimecrolimus Cream in the Long-Term Management of Atopic Dermatitis in Adults: A Six-Month Study

By  

Dermatology, Vol. 205, Iss. 3, 2002-10 ,pp. : 271-277

Karger

Access to resources Recommend Favorite

Efficacy and Safety of Tacrolimus versus Pimecrolimus for the Treatment of Atopic Dermatitis in Children: A Network Meta-Analysis

By  

Dermatology, Vol. 231, Iss. 1, 2015-05 ,pp. : 41-49

Karger

Access to resources Recommend Favorite